Ppd Inc (PPD) Growth Rates Comparisons to Medical Laboratories Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
Ppd Inc   (NASDAQ: PPD)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Ppd Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PPD Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 26.5 % 11.49 % 17.72 % 19.98 %
Q / Q Revenue Growth (Q3 MRQ) -0.93 % 2.89 % 3.3 % 2.27 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 34.71 % 31.04 % 19.09 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) 5.89 % 2.81 % 4.13 % 4.45 %
Revenue 5 Year Average Growth - 21.64 % 10.85 % 9.03 %


PPD's Growth Comparisons in III. Quarter 2021




Strong but slowing Revenue rise by Ppd Inc of 26.5% year on year , in the third quarter 2021 to 1.56 billions, was higher than the 11.49% rise in the Medical Laboratories industry, and 17.72% improvement in the Healthcare sector. Despite modest Sales rises in the Healthcare sector and in the Medical Laboratories industry, Ppd Inc reported above average market Sales growth.

Top-line fell by -0.93% from the second quarter. Average annual sales growth for Ppd Inc is %, while S & P 500's average yearly sales increase is 9.03%, including only Businesses with the third quarter 2021 financial results.


Growth Rates of PPD's Income in the third quarter 2021


PPD Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 32.03 % -11.34 % 31.58 % 56.95 %
Sequential Operating Income Change (Q3 MRQ) 26.68 % 6.49 % 0.75 % 4.85 %
Y / Y Operating Income Growth (Q3 TTM) 7.28 % 149.4 % 43.97 % 47.19 %
Sequential Operating Income Growth (Q3 TTM) 10.32 % -3.39 % 13.17 % 11.57 %
Operating Income 5 Year Avg. Change - 13.4 % 2.2 % 8.2 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) 1758 % -36.82 % 87.23 % 63.17 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) 228.61 % 2.16 % 40.33 % 1.61 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) 361.18 % 211.59 % 50.22 % 72.74 %
Sequential Income from Cont. Ops. Change (Q3 TTM) 148.29 % -1.41 % 22.65 % 11.82 %
Income from Cont. Ops. 5 Year Avg. Change - 16.52 % 10.33 % 76.07 %

PPD Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) 1758 % -37.02 % 86.56 % 63.98 %
Q / Q Net Income Growth (Q3 MRQ) 228.61 % 3.79 % 38.73 % -3.37 %
Y / Y Net Income Change (Q3 TTM) 537.56 % 212.24 % 51.77 % 74.54 %
Sequential Net Income Change (Q3 TTM) 76.06 % -1.4 % 22.62 % 11.84 %
Net Income 5 Year Avg. Growth - 16.06 % 1.77 % 4.21 %

PPD's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) 193.33 % -45.75 % 87.23 % 63.17 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) 158.82 % -0.31 % 40.33 % 1.61 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 586.67 % - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) 39.19 % 161.94 % 0.38 % 99.39 %
EPS from Cont. Ops. 5 Year Avg. Growth - 21.77 % 10.33 % 76.07 %



PPD EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) 186.67 % -45.92 % 86.56 % 76.07 %
Q / Q EPS Net Growth (Q3 MRQ) 168.75 % 1.28 % 38.73 % -3.37 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - 2639.73 % - 29709.81 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) 38.36 % 182.41 % - 99.39 %
EPS Net 5 Year Avg. Change - 16.06 % 1.77 % 4.21 %



Despite the -45.92% decline in Medical Laboratories industry, Ppd Inc showed impressive surge in EPS in the third quarter by 186.67% from the same quarter a year ago, to $0.43, Healthcare sector soar 86.56%. Although Medical Laboratories industry's earnings per share were softer then 63.98% overall market growth, Ppd Inc and the Healthcare sector have delivered above the average market earnings per share.

The Company's sequential EPS growth rate was very impressive 168.75% from the second quarter. Average yearly income per share growth for Ppd Inc is %, while S & P 500's average annual income per share growth is 4.21% over the five years, including only Businesses with the third quarter 2021 earnings results.

PPD Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) 185.19 % -20.86 % 45.84 % 107.81 %
Sequential Free Cash Flow Change (Q3 MRQ) 111.97 % 15.84 % 45.84 % 9.78 %
Y / Y Free Cash Flow Change (Q3 TTM) 219.29 % 99.63 % 38.98 % 20.32 %
Sequential Free Cash Flow Change (Q3 TTM) 28.51 % 1.2 % 12.39 % 13.48 %
Free Cash Flow 5 Year Avg. Change - 26.51 % 14.45 % 20.95 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - -56.85 % 11.79 % -
Sequential Net Cash Flow Change (Q3 MRQ) 82.52 % - 81.12 % -
Y / Y Net Cash Flow Change (Q3 TTM) - 32.09 % -83.49 % -71.06 %
Sequential Net Cash Flow Change (Q3 TTM) - -25.9 % -29.29 % 222.03 %
Net Cash Flow 5 Year Avg. Change - - 45.88 % 111.49 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -26.3 % 0.64 % -1.9 % 14.24 %
Sequential Capital Expenditures Change (Q3 MRQ) 35.35 % -18.28 % -1.6 % 6.88 %
Y / Y Capital Expenditures Change (Q3 TTM) 64.46 % 19.63 % 13.4 % 10.46 %
Sequential Capital Expenditures Change (Q3 TTM) -4.77 % 2.09 % 2.13 % 2.1 %
Capital Expenditures 5 Year Avg. Change - 19.35 % 12.33 % 13.05 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.